{"id":5167,"date":"2020-09-23T13:15:00","date_gmt":"2020-09-23T13:15:00","guid":{"rendered":"https:\/\/irlab.se\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/"},"modified":"2020-09-23T13:15:00","modified_gmt":"2020-09-23T13:15:00","slug":"irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/","title":{"rendered":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista"},"content":{"rendered":"<p><span><span><span><span><span>F\u00f6rsta dag f\u00f6r handel p\u00e5 Nasdaq Stockholms huvudlista f\u00f6rv\u00e4ntas bli onsdagen den 30 september 2020, och sista dagen f\u00f6r handel p\u00e5 Nasdaq First North Premier Growth Market f\u00f6rv\u00e4ntas bli tisdagen den 29 september 2020.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>Bolagets aktier av serie A kommer att handlas med of\u00f6r\u00e4ndrat kortnamn (IRLAB A) och ISIN-kod (SE0012675361). Inga nya aktier kommer att emitteras i samband med listbytet och Bolagets aktie\u00e4gare beh\u00f6ver inte vidta n\u00e5gra \u00e5tg\u00e4rder med anledning av listbytet.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><span><span><span><span>&#8221;Noteringen av IRLAB p\u00e5 Nasdaq Stockholms huvudlista medf\u00f6r \u00f6kad synlighet och transparens och \u00e4r en kvalitetsst\u00e4mpel f\u00f6r v\u00e5r organisation och verksamhet. Vi ser detta som ett v\u00e4sentligt steg p\u00e5 v\u00e4gen mot att bli ett internationellt v\u00e4lrenommerat l\u00e4kemedelsutvecklingsbolag&#8221;, s\u00e4ger Nicholas Waters, VD.<\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><strong><span><span><span><span>Prospekt<\/span><\/span><\/span><\/span><\/strong><\/span><\/p>\n<p><span><span><span><span><span><span>IRLAB har uppr\u00e4ttat ett prospekt med anledning av upptagandet till handel av Bolagets aktier av serie A p\u00e5 Nasdaq Stockholm. Prospektet f\u00f6rv\u00e4ntas godk\u00e4nnas och registreras av Finansinspektionen och offentligg\u00f6ras p\u00e5 IRLAB:s hemsida, <\/span><\/span><\/span><\/span><a href=\"http:\/\/www.irlab.se\"><span><span><span><span><span><span>www.irlab.se<\/span><\/span><\/span><\/span><\/span><\/span><\/a><span><span><span><span>, omkring fredagen den 25 september 2020. <\/span><\/span><\/span><\/span><\/span><\/span><\/p>\n<p><span><strong><span><span><span><span>R\u00e5dgivare<\/span><\/span><\/span><\/span><\/strong><\/span><\/p>\n<p><span><span><span><span><span>MAQS Advokatbyr\u00e5 \u00e4r Bolagets legala r\u00e5dgivare med anledning av noteringen p\u00e5 Nasdaq Stockholm. <\/span><\/span><\/span><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB Therapeutics AB (\u201dIRLAB\u201d eller \u201cBolaget\u201d) meddelade idag att Nasdaq Stockholms bolagskommitt\u00e9 den 22 september 2020 beslutat att godk\u00e4nna IRLAB:s ans\u00f6kan om upptagande till handel av Bolagets aktier av serie A p\u00e5 Nasdaq Stockholms huvudlista. Godk\u00e4nnandet \u00e4r villkorat av att sedvanliga villkor uppfylls, d\u00e4ribland att ett prospekt godk\u00e4nns och registreras av Finansinspektionen. Bolagets aktier av serie A handlas f\u00f6r n\u00e4rvarande p\u00e5 Nasdaq First North Premier Growth Market under kortnamnet IRLAB A.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-5167","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB Therapeutics AB (\u201dIRLAB\u201d eller \u201cBolaget\u201d) meddelade idag att Nasdaq Stockholms bolagskommitt\u00e9 den 22 september 2020 beslutat att godk\u00e4nna IRLAB:s ans\u00f6kan om upptagande till handel av Bolagets aktier av serie A p\u00e5 Nasdaq Stockholms huvudlista. Godk\u00e4nnandet \u00e4r villkorat av att sedvanliga villkor uppfylls, d\u00e4ribland att ett prospekt godk\u00e4nns och registreras av Finansinspektionen. Bolagets aktier av serie A handlas f\u00f6r n\u00e4rvarande p\u00e5 Nasdaq First North Premier Growth Market under kortnamnet IRLAB A.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-23T13:15:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista\",\"datePublished\":\"2020-09-23T13:15:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\"},\"wordCount\":205,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\",\"name\":\"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2020-09-23T13:15:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","og_description":"IRLAB Therapeutics AB (\u201dIRLAB\u201d eller \u201cBolaget\u201d) meddelade idag att Nasdaq Stockholms bolagskommitt\u00e9 den 22 september 2020 beslutat att godk\u00e4nna IRLAB:s ans\u00f6kan om upptagande till handel av Bolagets aktier av serie A p\u00e5 Nasdaq Stockholms huvudlista. Godk\u00e4nnandet \u00e4r villkorat av att sedvanliga villkor uppfylls, d\u00e4ribland att ett prospekt godk\u00e4nns och registreras av Finansinspektionen. Bolagets aktier av serie A handlas f\u00f6r n\u00e4rvarande p\u00e5 Nasdaq First North Premier Growth Market under kortnamnet IRLAB A.","og_url":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/","og_site_name":"IRLAB","article_published_time":"2020-09-23T13:15:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/"},"author":{"name":"","@id":""},"headline":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista","datePublished":"2020-09-23T13:15:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/"},"wordCount":205,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/","url":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/","name":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2020-09-23T13:15:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlab-therapeutics-har-godkants-for-notering-pa-nasdaq-stockholms-huvudlista\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB Therapeutics har godk\u00e4nts f\u00f6r notering p\u00e5 Nasdaq Stockholms huvudlista"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/5167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=5167"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/5167\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=5167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=5167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=5167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}